The impact of sociodemographic characteristics on diagnosis and access to disease-modifying treatment for patients with multiple sclerosis in Morocco

Multiple sclerosis (MS) is an autoimmune, inflammatory, and neurodegenerative disease of the central nervous system (Hirsch, 2002; Lassmann, 2018; Raymond et al., 2017). It is a potentially disabling, progressive chronic disease with significant social and economic impact(Béneton & Rumbach, 1999). MS typically affects young adults between 20 and 40 years old, with a median age of 32 years (Charil et al., 2006) and a female predominance. It is the leading cause of non-traumatic neurological disability in young adults (Multiple Sclerosis International Federation, Atlas of MS, 2020a).